by Jacquie Sneddon, Project Lead for the Scottish Antimicrobial Prescribing Group
Antimicrobial resistance (AMR) is one of the top threats to human healthcare with an estimated 50,000 deaths per year from resistant infection across Europe and the US. This figure will reach 10 million by 2050 unless we act now to tackle antimicrobial resistance.
With few new antibiotics in the pipeline we need to ensure we are using antibiotics appropriately – this means cut out unnecessary use and ensure when they are required that prescriptions comply with evidence-based guidance. This is the basis of antimicrobial stewardship. So what does this mean for pharmacists?
AMS is important in all sectors of pharmacy